statistiche ricercatore

PIGNATA, SALVATORE ANTONIO

Distribuzione geografica

Continente	#
EU - Europa	2.781
NA - Nord America	2.189
AS - Asia	1.178
SA - Sud America	370
Continente sconosciuto - Info sul continente non disponibili	130
AF - Africa	44
OC - Oceania	6
Totale	6.698

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2.127
RU - Federazione Russa	1.404
SG - Singapore	489
IT - Italia	349
CN - Cina	332
IE - Irlanda	313
BR - Brasile	309
SE - Svezia	252
DE - Germania	134
HK - Hong Kong	109
FR - Francia	103
VN - Vietnam	67
IN - India	56
PL - Polonia	55
FI - Finlandia	46
GB - Regno Unito	38
CA - Canada	28
AR - Argentina	23
BD - Bangladesh	22
NL - Olanda	20
JP - Giappone	18
ZA - Sudafrica	15
IQ - Iraq	14
AT - Austria	13
BE - Belgio	12
CI - Costa d'Avorio	12
ES - Italia	11
PK - Pakistan	11
MX - Messico	10
UZ - Uzbekistan	8
EC - Ecuador	7
ID - Indonesia	7
TR - Turchia	7
CL - Cile	6
CO - Colombia	6
CR - Costa Rica	6
JM - Giamaica	6
LT - Lituania	6
PA - Panama	6
AU - Australia	5
AZ - Azerbaigian	5
CZ - Repubblica Ceca	5
MA - Marocco	5
VE - Venezuela	5
PE - Perù	4
SA - Arabia Saudita	4
UA - Ucraina	4
A1 - Anonimo	3
AE - Emirati Arabi Uniti	3
BO - Bolivia	3
CH - Svizzera	3
PH - Filippine	3
PS - Palestinian Territory	3
PY - Paraguay	3
TN - Tunisia	3
UY - Uruguay	3
BG - Bulgaria	2
BY - Bielorussia	2
GE - Georgia	2
HN - Honduras	2
HU - Ungheria	2
IR - Iran	2
KG - Kirghizistan	2
KZ - Kazakistan	2
MU - Mauritius	2
NG - Nigeria	2
NP - Nepal	2
OM - Oman	2
RO - Romania	2
SN - Senegal	2
XK - ???statistics.table.value.countryCode.XK???	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
BQ - ???statistics.table.value.countryCode.BQ???	1
BS - Bahamas	1
DM - Dominica	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EU - Europa	1
GR - Grecia	1
JO - Giordania	1
KE - Kenya	1
KW - Kuwait	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LK - Sri Lanka	1
LV - Lettonia	1
MD - Moldavia	1
MK - Macedonia	1
ML - Mali	1
MY - Malesia	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PR - Porto Rico	1
QA - Qatar	1
SR - Suriname	1
Totale	6.576

Salva come PNG Salva come JPEG

Città	#
Ashburn	389
Moscow	383
Dublin	311
Singapore	301
Chandler	295
Dallas	220
Nyköping	176
San Jose	149
Hong Kong	108
Beijing	95
Munich	67
The Dalles	60
Princeton	53
Council Bluffs	52
Warsaw	52
Messina	48
Los Angeles	41
Medford	41
Lauterbourg	39
Dearborn	35
Des Moines	35
Bremen	33
New York	30
Jacksonville	29
Ann Arbor	27
São Paulo	26
Rome	24
Hyderabad	23
Helsinki	21
Buffalo	20
Ho Chi Minh City	20
Santa Clara	18
Milan	17
Tianjin	17
Turku	16
Frankfurt am Main	15
Montreal	13
Orem	13
Redondo Beach	13
Abidjan	12
Boardman	12
Brussels	12
Cambridge	12
Hanoi	12
Jinan	12
Kameido	10
London	10
Denver	8
Dong Ket	8
Düsseldorf	8
Falls Church	8
Nanjing	8
Palermo	8
Pune	8
Shenyang	8
Tokyo	8
Vienna	8
Belo Horizonte	7
Guangzhou	7
Johannesburg	7
Nuremberg	7
Phoenix	7
Porto Alegre	7
Redwood City	7
Rio de Janeiro	7
Shenzhen	7
Stockholm	7
Tashkent	7
Wilmington	7
Atlanta	6
Boston	6
Brasília	6
Brooklyn	6
Chennai	6
Curitiba	6
Fuzhou	6
Hebei	6
Nanchang	6
Seattle	6
Shanghai	6
Vittoria	6
West Jordan	6
Catania	5
Chicago	5
Haiphong	5
Hangzhou	5
Houston	5
San José	5
Santa Domenica	5
Sorocaba	5
Taizhou	5
Toronto	5
Amsterdam	4
Baghdad	4
Baku	4
Bexley	4
Blumenau	4
Changsha	4
Clifton	4
Dhaka	4
Totale	3.741

Salva come PNG Salva come JPEG

Nome	#
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA.	328
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology	280
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy	205
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience	204
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI	202
Association of parathyroid carcinoma and thyroid disorders: A clinical review	194
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC)	193
223RA-dichloride use in patients affected by bone metastases from castration-resistant prostate cancer: single centre experience	193
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC)	189
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients	183
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot	182
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study	181
Usefulness of PET-CT scan in recurrent thyroid cancer	177
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy.	173
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation	173
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario	171
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy	169
Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study	167
Renal Function Evaluation in PRRT Retreatments	158
From clinical trials to the front line: Vinflunine for treatment of urothelial cell carcinoma at the National Cancer Institute of Naples	157
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients	156
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy	152
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation	151
PRRT retreatments: renal function evaluation	150
Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients	149
un caso di carcinoma delle paratiroidi associato ad adenoma autonomo omolaterale della tiroide	143
Can peptide receptor radionuclide therapy (PRRT) be useful in radioiodine-refractory differentiated thyroid cancer?	139
Corrigendum: Pazopanib in metastatic renal cancer: A "real-world" experience at national cancer institute "Fondazione G. Pascale" [Front. Pharmacol., 7, 287, (2016)] doi: 10.3389/fphar.2016.00287	136
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020	134
Pazopanib in metastatic renal cancer: A "real-world" experience at National Cancer Institute "Fondazione G. Pascale"	132
Is dual tracer PET/CT a prognostic biomarker in the PRRT enrollment of GEP-NET patients?	130
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223	126
Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: The prospective observational scoop trial results	125
Very early PSA response to abiraterone in mCRPC patients: A novel prognostic factor predicting overall survival	123
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario	122
The sensitivity and positive predictive value (PPV) of I-131-post-therapy whole body scan is higher than serum Tg values in detecting metastases in early stage of differentiated thyroid cancer patients	122
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients	118
Theranosticsin nuclear medicine and oncology	109
Post-operative radioiodine therapy (RaIT) as adjuvant therapy in low–intermediate risk differentiated thyroid cancer	96
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose	67
Sequencing radium 223 (RA223) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the daily practice: Preliminary results from a retrospective study in Italian centers	65
Peptide receptor radionuclide therapy plus somatostatin analogues for a neuroendocrine tumour combined and maintenance treatment	63
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra	48
null	24
null	23
null	16
Totale	6.698

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	23.592
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	23.592

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	349	0	35	6	7	21	10	8	28	5	39	48	142
2022/2023	996	86	128	48	84	71	90	17	58	369	10	22	13
2023/2024	243	20	26	13	28	24	42	16	12	0	27	5	30
2024/2025	1.106	12	30	18	51	78	38	34	209	261	80	141	154
2025/2026	3.254	222	177	244	140	250	663	399	456	420	176	39	68
2026/2027	101	40	61	0	0	0	0	0	0	0	0	0	0
Totale													6.698